Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Lewko

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
In Vivo (Athens, Greece)|November 1, 1994
Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC)R K Oldham, W M Lewko, R W Good, et al.
Cancer Letters|March 1, 1981
Blocking basement membrane collagen deposition inhibits the growth of 7,12-dimethylbenzanthracene-induced rat mammary tumorsM S Wicha, L A Liotta, W M Lewko, et al.
Cancer Biotherapy|January 1, 1994
Growth of tumor derived activated T-cells for the treatment of cancerW M Lewko, R W Good, D Bowman, et al.
Cancer Research|July 1, 1981
Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen productionW M Lewko, L A Liotta, M S Wicha, et al.
Cancer Biotherapy|January 1, 1995
Interleukin-15 and the growth of tumor derived activated T-cellsW M Lewko, T L Smith, D J Bowman, et al.
Molecular Biotherapy|January 1, 1989
Chemosensitivity testing in a tumor acquisition, propagation, and preservation programW M Lewko, S K Nayak, W J Hubbard, et al.
Clinical Chemistry|August 1, 1989
Tumor-derived activated cells: preliminary laboratory and clinical resultsR K Oldham, J R Maleckar, C S Friddell, et al.
Breast Cancer Research and Treatment|December 1, 1990
Cultured breast cystosarcoma phylloides cells and applications to patient therapyW M Lewko, R Vaghmar, J R Maleckar, et al.
Journal of the National Cancer Institute|November 1, 1989
Activation and expansion of tumor-derived activated cells for therapeutic useJ R Maleckar, C S Friddell, A Sferruzza, et al.
Cancer|October 15, 1989
Tumor acquisition, propagation, and preservation. The culture of human colorectal cancerW M Lewko, P Ladd, D Hubbard, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
In Vivo (Athens, Greece)|November 1, 1994
Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC)R K Oldham, W M Lewko, R W Good, et al.
Cancer Letters|March 1, 1981
Blocking basement membrane collagen deposition inhibits the growth of 7,12-dimethylbenzanthracene-induced rat mammary tumorsM S Wicha, L A Liotta, W M Lewko, et al.
Cancer Biotherapy|January 1, 1994
Growth of tumor derived activated T-cells for the treatment of cancerW M Lewko, R W Good, D Bowman, et al.
Cancer Research|July 1, 1981
Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen productionW M Lewko, L A Liotta, M S Wicha, et al.
Cancer Biotherapy|January 1, 1995
Interleukin-15 and the growth of tumor derived activated T-cellsW M Lewko, T L Smith, D J Bowman, et al.
Molecular Biotherapy|January 1, 1989
Chemosensitivity testing in a tumor acquisition, propagation, and preservation programW M Lewko, S K Nayak, W J Hubbard, et al.
Clinical Chemistry|August 1, 1989
Tumor-derived activated cells: preliminary laboratory and clinical resultsR K Oldham, J R Maleckar, C S Friddell, et al.
Breast Cancer Research and Treatment|December 1, 1990
Cultured breast cystosarcoma phylloides cells and applications to patient therapyW M Lewko, R Vaghmar, J R Maleckar, et al.
Journal of the National Cancer Institute|November 1, 1989
Activation and expansion of tumor-derived activated cells for therapeutic useJ R Maleckar, C S Friddell, A Sferruzza, et al.
Cancer|October 15, 1989
Tumor acquisition, propagation, and preservation. The culture of human colorectal cancerW M Lewko, P Ladd, D Hubbard, et al.
Pageof 3